Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aadi Biosciences Inc (AADI)
Aadi Biosciences Inc (AADI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 173,448
  • Shares Outstanding, K 24,395
  • Annual Sales, $ 1,120 K
  • Annual Income, $ -110,090 K
  • 60-Month Beta 1.25
  • Price/Sales 11.42
  • Price/Cash Flow 3.90
  • Price/Book 1.10
Trade AADI with:

Options Overview Details

View History
  • Implied Volatility 97.29% ( +97.29%)
  • Historical Volatility 70.53%
  • IV Percentile 73%
  • IV Rank 53.10%
  • IV High 183.02% on 01/19/23
  • IV Low 0.21% on 10/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 62
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 966
  • Open Int (30-Day) 731

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.60
  • Number of Estimates 3
  • High Estimate -0.54
  • Low Estimate -0.64
  • Prior Year -0.66
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.80 +4.56%
on 03/28/23
11.00 -35.36%
on 03/01/23
-3.66 (-33.98%)
since 02/28/23
3-Month
6.80 +4.56%
on 03/28/23
13.45 -47.14%
on 01/30/23
-4.92 (-40.90%)
since 12/28/22
52-Week
6.80 +4.56%
on 03/28/23
18.47 -61.51%
on 04/05/22
-10.03 (-58.52%)
since 03/28/22

Most Recent Stories

More News
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Tops Revenue Estimates

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 20% and 14.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AADI : 7.12 (+0.14%)
ALNY : 199.88 (+2.44%)
Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

AADI : 7.12 (+0.14%)
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

AADI : 7.12 (+0.14%)
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

Geron (GERN) delivered earnings and revenue surprises of 9.09% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

GERN : 2.20 (+2.80%)
AADI : 7.12 (+0.14%)
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Misses Revenue Estimates

Caribou Biosciences, Inc. (CRBU) delivered earnings and revenue surprises of 6.38% and 2.33%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

CRBU : 5.21 (+1.36%)
AADI : 7.12 (+0.14%)
Aadi Bioscience Announces Leadership Transition

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined...

AADI : 7.12 (+0.14%)
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

AADI : 7.12 (+0.14%)
Brookdale Senior Living (BKD) Reports Q4 Loss, Tops Revenue Estimates

Brookdale (BKD) delivered earnings and revenue surprises of 69.77% and 1.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BKD : 2.99 (-0.33%)
AADI : 7.12 (+0.14%)
Aadi Bioscience, Inc. (AADI) Upgraded to Buy: What Does It Mean for the Stock?

Aadi Bioscience, Inc. (AADI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AADI : 7.12 (+0.14%)
Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 9.33% and 18.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AADI : 7.12 (+0.14%)
TWST : 15.47 (+5.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 7.51
2nd Resistance Point 7.34
1st Resistance Point 7.22
Last Price 7.12
1st Support Level 6.94
2nd Support Level 6.77
3rd Support Level 6.65

See More

52-Week High 18.47
Fibonacci 61.8% 14.01
Fibonacci 50% 12.64
Fibonacci 38.2% 11.26
Last Price 7.12
52-Week Low 6.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar